Should all patients with type 2 diabetes be on daily aspirin for primary prevention of cardiovascular events?

MOspace/Manakin Repository

Breadcrumbs Navigation

Should all patients with type 2 diabetes be on daily aspirin for primary prevention of cardiovascular events?

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/7310

[+] show full item record


Title: Should all patients with type 2 diabetes be on daily aspirin for primary prevention of cardiovascular events?
Author: Johnson, Diane; Kraus, Connie
Keywords: aspirin therapy
primary prevention
Date: 2008-04
Publisher: Family Physicians Inquiries Network
Citation: Evidence Based Practice 11(4): 05-07.
Series/Report no.: Help Desk Answers
Abstract: No. Current recommendations are that only patients with type 2 diabetes who have additional cardiovascular risk factors (age >40 years, hypertension, dyslipidemia, albuminuria, tobacco use) should use daily low-dose aspirin. (SOR C, based on expert opinion.) However, these additional risks are found in a large number of adults with diabetes.
URI: http://hdl.handle.net/10355/7310

This item appears in the following Collection(s)

[+] show full item record